Named for the English pediatrician who identified it, Angelman syndrome (AS) is a rare neuro-genetic disorder that occurs in one in 15,000 live births. Characteristics include developmental delay, lack of speech, seizures, and walking and balance disorders. It is often misdiagnosed as cerebral palsy or autism, due to lack of awareness. Despite these constant challenges, individuals with Angelman syndrome have a happy demeanor, laugh frequently and are often smiling.
Angleman Syndrome Foundation is the largest non-governmental funder of AS specific research. More importantly, our research has brought forth new discoveries that bring hope for therapies and ultimately a cure for AS. Help us give them a reason to smile.
Ovid is working with patients and families to develop failed drugs for ...
Ovid Therapeutics and Lundbeck A/S pharmaceuticals have entered into a worldwide ...
The 2015 ASF Research Grants will conduct clinical and pre-clinical research ...
Angelman A to Z
Explore tips and anecdotes from fellow caregivers.
Attend our Biennial Conference
July 15-18, 2015 – Chicago
A free educational resource
AS Behaviors Informational Series
Explore the behavior modules
Meet the Family Resource Team
Have questions or need advice?
AS specific healthcare
Watch our video about AS Diagnosis
The Angelman Syndrome Foundation is the largest non-governmental funder of Angelman syndrome-specific research, and has invested more than $8 million in Angelman syndrome research to date.